Anemia in COPD: A systematic review of the prevalence, quality of life, and mortality

Respiratory Care

Volumn 56, Issue 5, 2011, Pages 644-652

  Yohannes, Abebaw Mengistu ^a   Ershler, William Baldwin ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HARBOR HOSPITAL   (United States)

Author keywords

Anemia; COPD; Healthcare utilization; Morbidity; Mortality; Quality life

Indexed keywords

HEMOGLOBIN;

AGE; ANEMIA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONSENSUS; GENDER; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; MORTALITY; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

ANEMIA; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SURVIVAL RATE; UNITED STATES;

EID: 79957438361     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01002     Document Type: Review

References (52)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163(5):1256-1276.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-773.
3. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007;30(5):993-1013.
4. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349(9064):1498-1504.
5. Niederlander E. Cause of death in the EU. Statistics in focus - population and social conditions. Eurostat (European Communities) 2005; 101:1-12.
6. Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of Survival in COPD: more than just the FEV1. Respir Med 2008;102(Suppl 1): S27-S35.
7. Barr RG, Celli BR, Mannino DM, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 2009;122(4):348-355.
8. U.S. Department of Health and Human Services. National Institutes of Health National Heart Lung and Blood Institute. Morbidity and Mortality: 2009 Chart book on Cardiovascular, Lung and Blood Diseases.
9. Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005;128(3):1201-1208.
10. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165-1185.
11. Rennard SI. Inflammation in COPD: a link to systemic comorbidities. Eur Respir Rev 2007;16(105):91-97.
12. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 2006;35(5):457-459.
13. Similowski T, Agusti A, MacNee W, Schonhofer B. The potential impact of Anemia of chronic disease in COPD. Eur Respir J 2006; 27(2):390-396.
14. Nutritional anemias. Report of a WHO Scientific Group. WHO Tech Rep Sr 1968;405(1):5-37.
15. Izaks GJ, Westednorop RGJ, Knook DL. The definition of Anemia in older persons. JAMA 1999;281(18):1714-1717.
16. Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006;6:23.
17. Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006;4:17.
18. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006;111(3):365-370.
19. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007;29(5):923-929.
20. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005;127(3):825-829.
21. Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin 2008;24(4):1123-1130.
22. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352(10):1011-1023.
23. Tassiopoulos S, Kontos A, Konstantopoulos K, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med 2001; 95(6):471-475.
24. Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80(7):1639-1647.
25. Cartwright GE. The anemia of chronic disorders. Semin Hematol 1966;3(4):351-375.
26. Cash JM, Sears DA. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med 1989;87(6):638-644.
27. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagiolia R, et al. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure. Eur Heart J 2005;26(21):2232-2237.
28. Moldawer LL, Gelin J, Schersten T, Lundholm KG. Circulating interleukin 1 and tumor necrosis factor during inflammation. Am J Physiol 1987, 253(6 Pt 2):R922-R928.
29. Means RT, Jr., Krantz SB. Inhibition of human erythroid colonyforming units by interferons alpha and beta: differing mechanisms despite shared receptor. Exp Hematol 1996;24(2):204-208.
30. Means RT, Jr., Dessypris EN, Krantz SB. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 1992;150(1):59-64.
31. Maccio A, Madeddu C, Massa D, et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood 2005;106(1):362-367.
32. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271-1276.
33. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306(5704):2090-2093.
34. Raj DS. Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 2009;38(5):382-388.
35. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004; 11(4):251-254.
36. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006; 290(2):G199-G203.
37. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005;106(6): 2196-2199.
38. Roy CN, Andrews NC. Anemia of inflammation: the hepcidin link. Curr Opin Hematol 2005;12(2):107-111.
39. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004;113(9):1251-1253.
40. Dallalio G, Law E, Means RT, Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006;107(7):2702-2704.
41. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104(8):2263-2268.
42. KP. [Anemia in COPD: should it be taken into consideration?]. Arch Bronconeumol 2007;43(7):392-398. Article in Spanish.
43. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797-799.
44. Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anaemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998;26(11):1824-1828.
45. Cappell MS, Nadler SC. Increased mortality of acute upper gastrointestinal bleeding in patients with chronic obstructive pulmonary disease. A case controlled, multiyear study of 53 consecutive patients. Dig Dis Sci 1995;40(2):256-262.
46. Upchurch GR, Jr., Proctor MC, Henke PK, et al. Predictors of severe morbidity and death after elective abdominal aortic aneurysmectomy in patients with chronic obstructive pulmonary disease. J Vasc Surg 2003;37(3):594-599.
47. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
48. Mahler DA, Jones PW. Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med 1997;18(3):457-469.
49. Theander K, Unosson M. Fatigue in patients with chronic obstructive pulmonary disease. J Adv Nurs 2004;45(2):172-177.
50. Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile G, Ramello M, Grossi F. Fatigue: a main component of anemia symptomatology. Semin Oncol 2001;28(2 Suppl 8):15-18.
51. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25-31; discussion 33-37.
52. Schünemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005;25(1):31-40.